Pulmonary hypertension epidemiology and demographics: Difference between revisions
Jose Loyola (talk | contribs) No edit summary |
Jose Loyola (talk | contribs) No edit summary |
||
Line 30: | Line 30: | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category: | [[Category:Needs English Review]] |
Revision as of 16:24, 11 May 2021
Pulmonary Hypertension Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pulmonary hypertension epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Pulmonary hypertension epidemiology and demographics |
Pulmonary hypertension epidemiology and demographics in the news |
Blogs on Pulmonary hypertension epidemiology and demographics |
Risk calculators and risk factors for Pulmonary hypertension epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ralph Matar; José Eduardo Riceto Loyola Junior, M.D.[2]
Overview
Pulmonary arterial hypertension has been considered as a disease of young women. The mean age of patients in the U.S. registry was 36 years and the overall female-to-male ratio was 1.7:1.
Epidemiology and Demographics
Incidence
- While previously considered a rare disease, the most recent evidence from a French registry suggests that the incidence of new cases of pulmonary arterial hypertension is 0.20-0.30 cases per 100,000 individuals.[1]
Prevalence
- The prevalence of pulmonary hypertension is approximately 1.5-5 per 100,000 individuals.[2]
Age
- Pulmonary hypertension usually develops between the ages of 20 and 60, but it can occur at any age. The mean age of patients in the U.S. registry was approximately 36 years.[1]
Gender
- The female-to-male ratio for PH is approximately 1.7:1.[1]
- Idiopathic pulmonary hypertension (IPAH) which is more prevalent in women (3x more common), was considered the most common type of pulmonary arterial hypertension in a French registry. Usually it affects women between 30-60 years.[2]
- Males often face worse prognosis.[2]
References
- ↑ 1.0 1.1 1.2 Rich, S.; Dantzker, DR.; Ayres, SM.; Bergofsky, EH.; Brundage, BH.; Detre, KM.; Fishman, AP.; Goldring, RM.; Groves, BM. (1987). "Primary pulmonary hypertension. A national prospective study". Ann Intern Med. 107 (2): 216–23. PMID 3605900. Unknown parameter
|month=
ignored (help) - ↑ 2.0 2.1 2.2 Levine DJ (2021). "Pulmonary arterial hypertension: updates in epidemiology and evaluation of patients". Am J Manag Care. 27 (3 Suppl): S35–S41. doi:10.37765/ajmc.2021.88609. PMID 33710842 Check
|pmid=
value (help).